From: Tumor-related gene expression levels in pulmonary pleomorphic carcinoma
Case | Age/Sex | Stage | Chemotherapy | Relapse | Status | |
---|---|---|---|---|---|---|
1 | 70/M | T2bN1M0 | (+) | Distant | 16 mo | Dead |
AMR | ||||||
2 | 75/M | T2bN1M0 | (−) | (−) | 39 mo | Alive |
3 | 57/M | T2aN0M0 | (+) | Distant | 42 mo | Alive |
AMR, CBDCA + PTX | ||||||
4 | 77/M | T2bN0M0 | (−) | Distant | 9 mo | Dead |
5 | 68/M | T2aN0M0 | (+) | (−) | 57 mo | Alive |
DTX + TS1 | ||||||
6 | 80/M | T3N0M0 | (−) | Distant | 57 mo | Alive |
7 | 54/M | T3N0M0 | (−) | Locala | 2 mo | Dead |
8 | 47/M | T2bN0M0 | (+) | Distant | 12 mo | Dead |
TS1, CDDP + VNR, CBDCA + PTX | ||||||
9 | 48/F | T2aN1M1 | (+) | Distant | 14 mo | Dead |
CBDCA + DTX | ||||||
10 | 73/M | T2bN0M0 | (−) | (−)b | 2 mo | Dead |